Global market for gastrointestinal drugs to reach $48.4B by 2022: 5 notes

The global gastrointestinal drugs market will continue to grow through 2022, according to a GBI Research report.

Among its findings, the report notes:

1. The global market for gastrointestinal drugs reached $35.7 billion in 2015.

2. The market is expected to reach $48.4 billion by 2022, growing at a CAGR of 4.45 percent.

3. At present, AbbVie is leading the market; however, Takeda Pharmaceutical is expected to be the leading market player by the end of 2022.

4. Other key market players include Johnson & Johnson, Allergan and AstraZeneca.

5. GBI Research says that this increase in market value is, in part, due to a growing interest in biologic products.

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Learning Opportunities

Featured Webinars

Featured Whitepapers

Featured Podcast